Averill Master Fund, Ltd.
- SEC CIK
- 0001939329
In the past year, 4 open-market purchase filings worth $33.0M and 1 sale filing worth $80.4M.
Current role at each company
- MANE Veradermics, IncDirectoras of Aug 21, 2026
- BNTC Benitec Biopharma Inc.Director, 10% Owneras of Dec 29, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $33.0M
- 4 filings
- Sold
- $80.4M
- 1 filing
- Net
- −$47.5M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Averill Master Fund, Ltd. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
MANE Veradermics, Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 (view filing)6:11 PM ET | Aug 19 | 2 days | Montanova Capital, LLC and 3 othersDirector | SSaleCommon stock, par value $0.00001 per share | −750.0K | $107.25 | −$80.4M | −61.9%461.0K after | 2 lots |
| Feb 9, 2026 (view filing)6:28 PM ET | Feb 4-6 | 5 daysLate | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.00001 per share | +282.7K | $37.30 | +$10.5M | +118.9%520.5K after | 19 lots |
BNTC Benitec Biopharma Inc.
Director, 10% Owner8 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 (view filing)7:31 PM ET | Dec 23-29 | 6 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +144.2K | $13.20 | +$1.90M | +8.5%1.85M after | 6 lots |
| Dec 22, 2025 (view filing)7:45 PM ET | Dec 18-22 | 4 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +46.1K | $11.68 | +$539.0K | +2.6%1.83M after | 6 lots |
| Nov 10, 2025 (view filing)9:51 PM ET | Nov 7 | 3 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +1.48M | $13.50 | +$20.0M | +437.9%1.82M after | 2 lots |
| Apr 2, 2025 (view filing)4:37 PM ET | Mar 31 | 2 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +16.5K | $12.83 | +$211.7K | +1.6%1.07M after | 4 lots |
| Mar 28, 2025 (view filing)4:51 PM ET | Mar 26 | 2 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +900.0K | $13.00 | +$11.7M | +539.7%1.07M after | 2 lots |
| Dec 26, 2024 (view filing)4:28 PM ET | Dec 23-24 | 3 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +47.5K | $11.09 | +$527.2K | +5.2%960.6K after | 4 lots |
| Dec 5, 2024 (view filing)4:36 PM ET | Dec 3 | 2 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +42.0K | $9.60 | +$403.2K | +4.6%955.1K after | 2 lots |
| Nov 21, 2024 (view filing)4:24 PM ET | Nov 19-20 | 2 days | Montanova Capital, LLC and 3 othersDirector, 10% Owner | PPurchaseCommon stock, par value $0.0001 per share | +41.4K | $10.05 | +$416.6K | +4.6%950.3K after | 4 lots |